Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes

Use of non‐LDL‐C lipid‐lowering medications in patients with type 2 diabetes

Abstract Background A number of non‐low‐density lipoprotein cholesterol lipid abnormalities are associated with type 2 diabetes and insulin resistance, which may lead practitioners to use medications targeting these abnormal lipid fractions despite a lack of evidence or guideline recommendations. Me...

Full description

Bibliographic Details
Main Authors: Suzanne V. Arnold, Kensey Gosch, Nathan D. Wong, Vittal Hejjaji, Abhinav Goyal, Lawrence A. Leiter, Mikhail Kosiborod
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
diabetes mellitus
lipids
quality of care
triglycerides
Online Access:https://doi.org/10.1002/edm2.126

Internet

https://doi.org/10.1002/edm2.126

Similar Items